Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

44806 ARTÍCULOS , VIENDO DEL 2521 AL 2535

Neurodegeneration at the crossroads: the gut-brain axis and blood-brain barrier in Parkinson's disease - a review

Gamal NK, Fakhry R, Hatem Y, Rashed E, Marzouk R, Bukr AKM, Akawi N, George MY.

Front Pharmacol. 2026 May 8;17:1813134. doi: 10.3389/fphar.2026.1813134. eCollection 2026.

Research Progress of Natural Components Improving Parkinson's Disease by Regulating the Oxidative Stress

Jiang W, Li Z, Hu M, Zhang H, Tian X, Chen Q, Zhao Y, Xu K, Qu Y, Wei S, Wang X, Geng X.

Phytother Res. 2026 Apr;40(4):1810-1836. doi: 10.1002/ptr.70214. Epub 2026 Feb 1.

Mechanistic insights into the role of nuclear receptor related-1 protein in Parkinson's disease

Sharma V, Singh TG.

J Neuroimmunol. 2026 May;414:578893. doi: 10.1016/j.jneuroim.2026.578893. Epub 2026 Feb 16.

Sources of Oxidative Stress in Parkinson's Disease: Pathways and Therapeutic Implications

Yordanov Y, Stefanova D, Kondeva-Burdina M, Tzankova V.

Antioxidants (Basel). 2026 Feb 2;15(2):187. doi: 10.3390/antiox15020187.

Freezing of Gait in Parkinson's Disease: A Scoping Review on the Path Towards Real-Time Therapies

Singhal M, Grannie C, Burnette M, Hernandez ME, Hegazy SA.

Sensors (Basel). 2026 Mar 25;26(7):2042. doi: 10.3390/s26072042.

Mechanisms of Exercise-Mediated Regulation of the Gut-Brain Axis in Parkinson's Disease

Men X, Wu W.

Nutrients. 2026 May 21;18(10):1639. doi: 10.3390/nu18101639.

Molecular mechanisms underlying Parkinson's disease and role of phytochemicals, α-synuclein, sirtuins, and incretin mimetics in potential therapy

Juthi SS, Ansari P, Ahmed MF, Khan JT, Seidel V, Kumar S, Kumari R, McKillop A, Abdel-Wahab YHA, Flatt PR.

Front Pharmacol. 2026 Mar 26;17:1798309. doi: 10.3389/fphar.2026.1798309. eCollection 2026.

Integrative Advances in Parkinson's Disease: Pathophysiology, Diagnostics, Therapeutics, and Experimental Modeling

Sunder K.

Restor Neurol Neurosci. 2026 Apr 20:9226028261436622. doi: 10.1177/09226028261436622. Online ahead of print.

Living with the Unknown: Intolerance of Uncertainty in Parkinson's Disease

McDaniels B, Pontone GM, Pushparatnam K, Subramanian I.

Mov Disord Clin Pract. 2026 Oct;13(10):2353-2364. doi: 10.1002/mdc3.70679. Epub 2026 May 14.

Fatigue-Inducing Protocols in Parkinson's Disease: Implications for Gait Assessment and Rehabilitation: A Systematic Review

Majlesi M, Azadian E, Farahpour N, Bakhtiarian R, Nobari H.

Parkinsons Dis. 2026 Jan 5;2026:8822220. doi: 10.1155/padi/8822220. eCollection 2026.

The Possible Impact of Montelukast in Parkinson's Disease: A Substantial Contribution

Turkistani A, Al-Kuraishy HM, Al-Gareeb AI, Eliwa D, Alexiou A, Alnoaman H, Papadakis M, Batiha GE.

J Geriatr Psychiatry Neurol. 2026 Jan 13:8919887251409836. doi: 10.1177/08919887251409836. Online ahead of print.

The role of indole metabolites derived from gut microbiota in Parkinson's disease: A comprehensive review

Meng S.

Brain Res Bull. 2026 Apr;237:111775. doi: 10.1016/j.brainresbull.2026.111775. Epub 2026 Feb 10.

Exploring the Role of Food and Food-Related Compounds in Parkinson's Disease

Trezzi I, Rizzo G, Giampieri F, Battino M, Baroni L.

Foods. 2026 Feb 2;15(3):514. doi: 10.3390/foods15030514.

Gene therapy targeting synaptopathy linked with Alzheimer's and Parkinson's disease

Panda SP, Saraswat N, Singh V.

Neuroscience. 2026 Apr 16;600:227-242. doi: 10.1016/j.neuroscience.2026.02.035. Epub 2026 Feb 21.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias